國家衛生研究院 NHRI:Item 3990099045/10126

NHRI > Institute of Biotechnology and Pharmaceutical Research > John Tsu-An Hsu > Periodical Articles > Item 3990099045/10126

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10126

Title:	Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer
Authors:	Wang, HY;Chang, YL;Cheng, CC;Chao, MW;Lin, SI;Pan, SL;Hsu, CC;Liu, TW;Cheng, HC;Tseng, CP;Liu, SJ;Tsai, HJ;Chang, HY;Hsu, JT
Contributors:	Institute of Biotechnology and Pharmaceutical Research;Division of Health Services and Preventive Medicine;Division of Vaccine Research and Development;National Institute of Cancer Research;Division of Biostatistics and Bioinformatics
Abstract:	The epidermal growth factor receptor (EGFR)-targeting tyrosine kinase inhibitors (TKIs) have shown remarkable benefits in non-small cell lung cancer (NSCLC) patients with drug-sensitive mutations in the EGFR gene. Responsive patients are usually continuously prescribed with TKIs until disease progression. Glucocorticoids (GCs) are potent homeostasis maintaining drugs and are frequently used in cancer patients to alleviate discomforts caused by anti-cancer therapies. Several previous studies reported that concomitant use of GCs may compromise the efficacy of chemo-therapeutics in patients with solid tumors. Little is known in the concomitant use of target therapy with GCs in treating NSCLC. In this study, we hypothesized that concomitant use of GCs in EGFR-TKI therapy may be detrimental and addressed this issue using cell cultures and xenograft studies followed by a retrospective population study based on data from the Taiwan national health insurance system. In cell cultures and xenograft studies, GCs were shown to unequally compromise the anti-cancer efficacy of TKIs in both PC9 and NCI-H1975 NSCLC cells models. In the retrospective population study, patients with similar disease status that were co-medicated with GCs had a significantly higher risk of disease progression.
Date:	2016-12
Relation:	Oncotarget. 2016 Dec;7(52):85917-85928.
Link to:	http://dx.doi.org/10.18632/oncotarget.13185
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000391422500022
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85007492453
Appears in Collections:	[John Tsu-An Hsu] Periodical Articles [Hsing-Yi Chang] Periodical Articles [Chih-Cheng Hsu] Periodical Articles [Shih-Jen Liu] Periodical Articles [Tsang-Wu Liu] Periodical Articles [Hui-Ju Tsai] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB27835586.pdf		2508Kb	Adobe PDF	530	View/Open

Loading...